Form 4: Hims & Hers Health CFO Oluyemi Okupe Executes Stock Option and Sells Shares Under 10b5-1 Plan

Hims & Hers Health CFO Oluyemi Okupe exercised stock options and sold shares of Class A Common Stock on September 3, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On September 3, 2024, Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc., executed stock options and sold shares of Class A Common Stock.
• The transactions were carried out under a Rule 10b5-1 trading plan adopted on May 31, 2024.
• Okupe exercised options to acquire 9,199 shares at a price of $5.01 per share.
• Concurrently, Okupe sold 9,199 shares at a weighted average price of $14.6025, 3 shares at $14.6, 1,008 shares at $14.5866, and 1,399 shares at $14.584.
• Following these transactions, Okupe directly owns 181,469 shares of Class A Common Stock and 834,284 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document simply reports transactions by an executive under a pre-arranged plan. There's no indication of positive or negative implications for the company.

Positives

• The transactions were conducted under a pre-arranged 10b5-1 trading plan, which is generally viewed as a transparent and compliant practice.

Industry Context

Executive stock transactions are common and closely monitored, especially in publicly traded companies like Hims & Hers Health. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• Executive compensation packages often include stock options to align management's interests with those of shareholders.
• Rule 10b5-1 trading plans are widely used by corporate insiders to manage their stock sales in a compliant manner.
• The vesting schedule of the options is typical, with a portion vesting after one year and the remainder vesting monthly over the following three years.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates